HCPLive

Hospital Medicine
The MD Magazine Hospital Medicine specialty page provides clinical news and articles, coverage from conferences and meetings, links to condition-specific resources, and videos and other content.

Conditions

Conferences

Latest CME

Latest Headlines

Mark Komrad: Progressing from Scholarship to Activism for a Cause
The issue of physician assisted suicide can cause people to fervently pick one side or another. For some, their belief is so strong that they are moved to do things they may not have done in their career beforehand.
For many psychiatrists one of their biggest challenges in their daily practice is working to show patients that suicide is not the solution to their problems. Changes in the criteria for physician assisted suicide in Europe which include allowing mental illness as a criteria can fly in the face of that mission.
The issue of physician assisted suicide is one that has been debated both in the medical community and in the general population. Recent law changes by some European countries have brought the issue to the forefront perhaps more than ever before.
The study identified several characteristics to observe in HIV patients who develop broadly neutralizing HIV antibodies (bnAbs), which occur naturally in about one percent of those infected with the disease and could be key in an eventual vaccine. Black patients were found more likely to develop them than white.
There have been great strides made in recent years to help treat patients diagnosed with heart disease. As technology improves and new medications are developed it will be important to ensure they can get to the patients who need them most.
While lifestyle modifications and changes in diet can help prevent heart disease in men and women alike there are some distinct differences when it comes to treating these patients once a diagnosis is made.
As more has been learned over the years about heart disease there is also a greater awareness of the impact it can have on women. Because of this increased awareness a greater effort is underway to help catch these conditions before they become fatal.
The drug, a fully human monoclonal antibody that has impressed equally in asthma and atopic dermatitis trials, may be approved for market as soon as March of 2017.
In the field of neurosurgery it can seem like each new day is the future. Even still there are goals to achieve that may not be reached until many years down the road.

Most Popular in Hospital Medicine

Recent Published Journal

@MDMagazine

$vacMongoViewPlus$ $vAR$